Javascript must be enabled to continue!
The clinical evaluation of transcatheter closure of perimembranous ventricular septal defects with the Amplatzer duct occluder II
View through CrossRef
Objectives
Investigate the feasibility of perimembranous ventricular septal defects closure with the Amplatzer duct occluder II.
Methods
2 female infants with small perimembranous ventricular septal defect, closed the VSD with Duct Occluder II. One is 3 years old, echocardiogram showed the diameter of VSD is 5.5 mm in left ventricle side and 2.3 mm in right ventricle side. The distance of superior border of VSD to aortic valve is 4 mm, the other is 2 years and 10 months old, the diameter of VSD is 7.8 mm in left ventricle side and 2.0 mm in right ventricle side. 5.8 mm to aortic valve.
Results
One was selected 4 mm*4 mm Duct Occluder II and 5 F TorqVue Low Profile Delivery Catheter; the other was 3 mm* 4 mm Duct Occluder II and 4 F Delivery Catheter. Set up the arteriovenous pathway and release the left shed and right shed in turns. Echocardiogram showed no residual shunt and aortic regurgitation, but one infants has mild tricuspid regurgitation after procedure. The results of electrocardiogram are normal 2 days after procedure.
Conclusions
Transcatheter closure of small perimembranous ventricular septal defects in infants with the Amplatzer duct occluder II was a good alternative selection, mild impairment of vessel when using small delivery catheter. No complication was found such as residual shunt, valve regurgitation and arrhythmia just after procedure.
Title: The clinical evaluation of transcatheter closure of perimembranous ventricular septal defects with the Amplatzer duct occluder II
Description:
Objectives
Investigate the feasibility of perimembranous ventricular septal defects closure with the Amplatzer duct occluder II.
Methods
2 female infants with small perimembranous ventricular septal defect, closed the VSD with Duct Occluder II.
One is 3 years old, echocardiogram showed the diameter of VSD is 5.
5 mm in left ventricle side and 2.
3 mm in right ventricle side.
The distance of superior border of VSD to aortic valve is 4 mm, the other is 2 years and 10 months old, the diameter of VSD is 7.
8 mm in left ventricle side and 2.
0 mm in right ventricle side.
5.
8 mm to aortic valve.
Results
One was selected 4 mm*4 mm Duct Occluder II and 5 F TorqVue Low Profile Delivery Catheter; the other was 3 mm* 4 mm Duct Occluder II and 4 F Delivery Catheter.
Set up the arteriovenous pathway and release the left shed and right shed in turns.
Echocardiogram showed no residual shunt and aortic regurgitation, but one infants has mild tricuspid regurgitation after procedure.
The results of electrocardiogram are normal 2 days after procedure.
Conclusions
Transcatheter closure of small perimembranous ventricular septal defects in infants with the Amplatzer duct occluder II was a good alternative selection, mild impairment of vessel when using small delivery catheter.
No complication was found such as residual shunt, valve regurgitation and arrhythmia just after procedure.
Related Results
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Transcatheter closure of perimembranous ventricular septal defects with ductal occluders
Transcatheter closure of perimembranous ventricular septal defects with ductal occluders
AbstractBackground: To study the feasibility and complications associated with the use of ductal occluders for closure of perimembranous ventricular septal defects. Methods: A tota...
Off‐label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience
Off‐label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience
AbstractObjectiveWe sought to evaluate the feasibility, technical aspects, and outcome of transcatheter perimembranous ventricular septal defect (pmVSD) closure using duct occluder...
Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder
Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder
AIM
To evaluate whether transcatheter closure with the Amplatzer duct occluder offers an alternative to surgical treatment in infants with a persistent ductus art...
Presentation and Management of Cervical Thoracic Duct Cyst: A Systematic Review of the Literature
Presentation and Management of Cervical Thoracic Duct Cyst: A Systematic Review of the Literature
Abstract
Introduction
Thoracic duct cysts are an uncommon phenomenon, especially within the cervical region. Due to its limited reported cases, very little is known about its etiol...
ASSA13-15-6 Transcatheter Closure of Patent Ductus Arteriosus with Severe Pulmonary Hypertension Using Domestic Occluder in Adults
ASSA13-15-6 Transcatheter Closure of Patent Ductus Arteriosus with Severe Pulmonary Hypertension Using Domestic Occluder in Adults
Background
To evaluate the clinical efficacy of transcatheter closure of patent ductus arteriosus (PDA) with severe pulmonary hypertention using domestic occluder...
The Incidence of Isolated Ventricular Septal Defect in Libyan Newborns
The Incidence of Isolated Ventricular Septal Defect in Libyan Newborns
This study aimed to evaluate the incidence and spontaneous closure of ventricular septal defects in a randomly selected newborn population, using color Doppler echocardiographic sc...
Assessment of Immediate, Short- and Long-Term Outcomes After Transcatheter Perimembranous Ventricular Septal Defect (PM VSD) Closure by KONAR-MF Occluder Device
Assessment of Immediate, Short- and Long-Term Outcomes After Transcatheter Perimembranous Ventricular Septal Defect (PM VSD) Closure by KONAR-MF Occluder Device
Background: Perimembranous ventricular septal defect (PM VSD) is the most prevalent congenital heart defect, traditionally managed by surgical closure with associated morbidity. Ob...

